Cited by 1,763Cardiac pacing and defibrillation studiesCardiac Arrest and ResuscitationHeart Failure Treatment and Management

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

Open access

Køber, Lars, Thune, Jens J., Nielsen, Jens C., Haarbo, Jens, Videbæk, Lars, Korup, Eva, Jensen, Gunnar, Hildebrandt, Per, Steffensen, Flemming H., Bruun, Niels E., Eiskjær, Hans, Brandes, Axel, Thøgersen, Anna M., Gustafsson, Finn, Egstrup, Kenneth, Videbæk, Regitze, Hassager, Christian, Svendsen, Jesper H., Høfsten, Dan E., Torp-Pedersen, Christian, Pehrson, Steen·2016·New England Journal of Medicine

DOI 10.1056/nejmoa1608029

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The benefit of an implantable cardioverter-defibrillator (ICD) in patients with symptomatic systolic heart failure caused by coronary artery disease has been well documented. However, the evidence for a benefit of prophylactic ICDs in patients with systolic heart failure that is not due to coronary artery disease has been based primarily on subgroup analyses. The management of heart failure has improved since the landmark ICD trials, and many patients now receive cardiac resynchronization therapy (CRT). METHODS: In a randomized, controlled trial, 556 patients with symptomatic systolic heart failure (left ventricular ejection fraction, ≤35%) not caused by coronary artery disease were assigned to receive an ICD, and 560 patients were assigned to receive usual clinical care (control group). In both groups, 58% of the patients received CRT. The primary outcome of the trial was death from any cause. The secondary outcomes were sudden cardiac death and cardiovascular death. RESULTS: After a median follow-up period of 67.6 months, the primary outcome had occurred in 120 patients (21.6%) in the ICD group and in 131 patients (23.4%) in the control group (hazard ratio, 0.87; 95% confidence interval [CI], 0.68 to 1.12; P=0.28). Sudden cardiac death occurred in 24 patients (4.3%) in the ICD group and in 46 patients (8.2%) in the control group (hazard ratio, 0.50; 95% CI, 0.31 to 0.82; P=0.005). Device infection occurred in 27 patients (4.9%) in the ICD group and in 20 patients (3.6%) in the control group (P=0.29). CONCLUSIONS: In this trial, prophylactic ICD implantation in patients with symptomatic systolic heart failure not caused by coronary artery disease was not associated with a significantly lower long-term rate of death from any cause than was usual clinical care. (Funded by Medtronic and others; DANISH ClinicalTrials.gov number, NCT00542945 .).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1608029

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction
Moss, A. J., Zaręba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,885
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032423 · Cited by 5,812
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304
A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease
Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., & Hafley, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912163412503 · Cited by 2,489
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy
Kadish, A. H., Dyer, A. R., Daubert, J. P., Quigg, R. J., Estes, N. A. M., Anderson, K. P., Calkins, H. G., Hoch, D., Goldberger, J. J., Shalaby, A. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033088 · Cited by 2,078
Reduction in Inappropriate Therapy and Mortality through ICD Programming
Moss, A. J., Schuger, C. D., Beck, C. A., Brown, M. W., Cannom, D. S., Daubert, J. P., Estes, N. A. M., Greenberg, H., Hall, W. J., Huang, D. T.-C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211107 · Cited by 1,369

Flagged first, then by citations

Show all 18 references

Sorted by citations

Items 701–800 of 999

Eurasian Association of Cardiology (EAC)/ National Society of Heart Failure And Myocardial Disease (NSHFMD) guidelines for the diagnosis and treatment of chronic heart failure (2024)
Tereshchenko, S. N., Жиров, И. В., Uskach, T. M., Saidova, M. A., Sp, G., Rimskaya, E. M., Николаевна, Н. С., Narusov, O. Y., Safiullina, A. A., Tereshchenko, A. S., et al. (2024) · Eurasian heart journal · doi:10.38109/2225-1685-2024-2-6-76 · Cited by 8
Late gadolinium enhancement dispersion for predicting malignant arrhythmic events in patient with non-ischaemic dilated cardiomyopathy
Aquaro, G. D., Merlo, M., Barison, A., Luca, A. D., Restivo, L., Licordari, R., Todiere, G., Grigoratos, C., Faggioni, L., Cioni, D., et al. (2025) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeaf124 · Cited by 8
Economic Evaluations in Electrophysiology in the Last 15 Years: A Systematic Review of the Literature
Mei, D. A., Imberti, J. F., Vitolo, M., Bonini, N., Casali, E., Osoro, L., Casado-Arroyo, R., & Boriani, G. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm36206 · Cited by 8
Implantable Cardioverter-Defibrillators in Ischaemic Versus Non-Ischaemic Heart Failure: Insights from the VICTORIA Trial
Gouda, P., Alemayehu, W. G., Voors, A. A., Lam, C. S. P., Ezekowitz, J. A., Pieske, B. M., Butler, J., Westerhout, C. M., Yogasundaram, H., Sandhu, R. K., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.3731 · Cited by 8
Prediction of ventricular arrhythmias and sudden cardiac death by quantification and location of late gadolinium enhancement on cardiac magnetic resonance: a systematic review and meta-analysis
Jensen, T., Omara, S., Nielsen, J. M., Samuel, M., van der Geest, R. J., Kim, W. Y., & Zeppenfeld, K. (2025) · EP Europace · doi:10.1093/europace/euaf214 · Cited by 8
Self-citation
Jahresbericht 2016 des Deutschen Herzschrittmacher- und Defibrillator-Registers – Teil 2: Implantierbare Kardioverter-Defibrillatoren (ICD)
Herzschrittmacher, B., & Markewitz, A. (2018) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-018-0604-9 · Cited by 8
Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial (PAUSE-SCD): rationale and study design
on behalf of the PAUSE-SCD investigators, Chen, M., Wu, S., Yao, Y., Jiang, J. D., Jiang, C., Xue, Y., Zhan, X., Hu, H., Fu, G., et al. (2019) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-019-00535-w · Cited by 8
Long-term clinical outcomes after placement of an implantable cardioverter-defibrillator: does the etiology of heart failure matter?
Wasiak, M., Tajstra, M., Pyka, Ł., & Gąsior, M. (2020) · Kardiologia Polska · doi:10.33963/kp.15242 · Cited by 8
Cardiac resynchronization therapy using a pacemaker or a defibrillator: Patient selection and evidence to support it
Canterbury, A., & Saba, S. (2021) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2021.04.003 · Cited by 8
Pediatric and adult dilated cardiomyopathy are distinguished by distinct biomarker profiles
Gropler, M. R. F., Lipshultz, S. E., Wilkinson, J. D., Towbin, J. A., Colan, S. D., Canter, C. E., Lavine, K. J., & Simpson, K. E. (2021) · Pediatric Research · doi:10.1038/s41390-021-01698-x · Cited by 9
Clinical Implication of Genetic Testing in Dilated Cardiomyopathy
Lee, J., Lee, S. E., & Cho, M. (2021) · International Journal of Heart Failure · doi:10.36628/ijhf.2021.0024 · Cited by 8
Comments on the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
Pascual-Figal, D. A., González‐Juanatey, J. R., Bayés‐Genís, A., Cobo, M., Delgado, J. F., Molina, B. D., González‐Costello, J., López‐Fernández, S., Mesa-Rico, R., Villota, J. N., et al. (2022) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2021.11.023 · Cited by 8
Empfehlungen zur Sondenextraktion – Gemeinsame Empfehlungen der Deutschen Gesellschaft für Kardiologie (DGK) und der Deutschen Gesellschaft für Thorax‑, Herz- und Gefäßchirurgie (DGTHG)
Tilz, R. R., BOSCH, R. F., Butter, C., Kück, K., Richter, S., Sommer, P., Hakmi, S., Hanke, T., Knaut, M., Starck, C. T., et al. (2022) · Die Kardiologie · doi:10.1007/s12181-022-00550-8 · Cited by 8
Implantable Cardioverter-Defibrillator for Primary Prevention in Asia
Younis, A., & Wilkoff, B. L. (2023) · JACC Asia · doi:10.1016/j.jacasi.2022.11.014 · Cited by 8
Prediction of Sudden Cardiac Death: Looking Beyond Ejection Fraction
Chatterjee, N. A. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01871-0 · Cited by 8
Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction
Vicent, L., Garcia, J. A., Vázquez, R., González‐Juanatey, J. R., Rivera, M., Segovia, J., Pascual-Figal, D. A., Bover, R., Worner, F., Fernández‐Avilés, F., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12083028 · Cited by 9
Advanced heart failure: a contemporary approach
Chun, K., & Kang, S. (2023) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2023.159 · Cited by 9
Relationship of Mild to Moderate Impairment of Left Ventricular Ejection Fraction With Fatal Ventricular Arrhythmic Events in Cardiac Sarcoidosis
Akama, Y., Fujimoto, Y., Matsue, Y., Maeda, D., Yoshioka, K., Dotare, T., Sunayama, T., Nabeta, T., Naruse, Y., Kitai, T., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.032047 · Cited by 8
Cardiac magnetic resonance in advanced heart failure
Coraducci, F., Zan, G. D., Fedele, D., Costantini, P., Guaricci, A. I., Pavon, A. G., Teske, A. J., Cramer, M. J., Broekhuizen, L. N., van Osch, D., et al. (2024) · Echocardiography · doi:10.1111/echo.15849 · Cited by 8
Sudden death mechanisms in nonischemic cardiomyopathies: Insights gleaned from clinical implantable cardioverter-defibrillator trials
Steinberg, B. A., Mulpuru, S. K., Fang, J. C., & Gersh, B. J. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.09.025 · Cited by 8
Cardiac resynchronization therapy is associated with a reduction in ICD therapies as it improves ventricular function
Galve, E., Oristrell, G., Acosta, G., Ribera, A., Moya‐Mitjans, À., González, I. F., Pérez‐Rodon, J., & David Garcia-dorado, A. (2018) · Clinical Cardiology · doi:10.1002/clc.22958 · Cited by 8
Emerging Techniques for Cardiovascular PET
Robinson, A. A., & Bourque, J. M. (2019) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2019.0004 · Cited by 8
Association Between Mortality and Implantable Cardioverter-Defibrillators by Aetiology of Heart Failure: A Propensity-Matched Analysis of the WARCEF Trial
Lee, T. C., Qian, M., Mu, L., Tullio, M. R. D., Graham, S., Mann, D. L., Nakanishi, K., Teerlink, J. R., Lip, G. Y. H., Freudenberger, R. S., et al. (2019) · ESC Heart Failure · doi:10.1002/ehf2.12407 · Cited by 8
Arrhythmic burden among asymptomatic patients with ischemic cardiomyopathy and an implantable cardioverter-defibrillator
Sabbag, A., Glikson, M., Suleiman, M. A., Boulos, M., Goldenberg, I., Beinart, R., & Nof, E. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.03.030 · Cited by 8
Favorable five-year outcomes for heart failure diagnosed in younger patients without severe comorbidity
Madelaire, C., Gustafsson, F., Stevenson, L. W., Kristensen, S. L., Køber, L., Andersen, J., D’Souza, M., Torp-Pedersen, C. T., Gislason, G., & Schou, M. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.01.055 · Cited by 8
Self-citation
Cause-specific death and risk factors of 1-year mortality after implantable cardioverter-defibrillator implantation: a nationwide study
Alhakak, A., Østergaard, L., Butt, J. H., Vinther, M., Philbert, B. T., Jacobsen, P. K., Yafasova, A., Torp-Pedersen, C. T., Køber, L., Fosbøl, E. L., et al. (2020) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaa074 · Cited by 8
Self-citation
The benefits of defibrillator in heart failure patients with cardiac resynchronization therapy: A meta‐analysis
Long, Y., Hu, Y., Cui, D., Hu, S., & Liu, Z. (2020) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14150 · Cited by 8
Five-Year Survival and Use of Hospital Services Following ICD and CRT Implantation: Comparing Real-World Data with RCTs
Bottle, A., Faitna, P., Aylin, P. P., & Cowie, M. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13357 · Cited by 8
Inter-American Society of Cardiology (CIFACAH-ELECTROSIAC) and Latin-American Heart Rhythm Society (LAHRS): multidisciplinary review on the appropriate use of implantable cardiodefibrillator in heart failure with reduced ejection fraction
Gómez‐Mesa, J. E., Márquez-Murillo, M. F., Figueiredo, M. J. D. O., Berni-Betancourt, A., Jerez, A. M., Ayala, E. N., Pow-Chon-Long, F., Sáenz-Morales, L. C., Molano, L. F. P., Montes, M. C., et al. (2022) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-022-01425-4 · Cited by 8
Eurasian association of cardiology (EAC) guidelines for the prevention and treatment of ventricular heart rhythm disorders and prevention of sudden cardiac death (2022)
Sp, G., Kostyukevich, M. V., Laiovich, L. I., Mironov, N. Y., Миронова, Н. А., Utsumueva, M. D., Khusyainova, D. R., Шлевков, Н. Б., Bazarov, B. C., Азизов, В. А., et al. (2022) · Eurasian heart journal · doi:10.38109/2225-1685-2022-4-6-67 · Cited by 10
New generation cardioverter‐defibrillator lead with a floating atrial sensing dipole: Long‐term performance
Şafak, E., ́Ancona, G. D., Kaplan, H., Caglayan, E., Kische, S., Öner, A. Ö., İnce, H., & Ortak, J. (2017) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13256 · Cited by 8
Myocardial recovery after cardiac resynchronization therapy in left bundle branch block‐associated idiopathic nonischemic cardiomyopathy: A NEOLITH II substudy
Wang, N. C., Hussain, A., ADELSTEIN, E. C., Althouse, A. D., Sharbaugh, M. S., Jain, S. K., Shalaby, A. A., Voigt, A., & Saba, S. (2018) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12603 · Cited by 8
Percutaneous treatment of mitral regurgitation in patients with impaired ventricular function: Impact of intracardiac electronic devices (from the German Transcatheter Mitral Valve Interventions Registry)
D’Ancona, G., İnce, H., Schillinger, W., Senges, J., Ouarrak, T., Butter, C., Seifert, M., Schau, T., Lubos, E., Boekstegers, P., et al. (2019) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.28127 · Cited by 8
Impact of LDB3 gene polymorphisms on clinical presentation and implantable cardioverter defibrillator (ICD) implantation in Chinese patients with idiopathic dilated cardiomyopathy
Wang, D., Lyu, J., Fang, J., Chen, J., Chen, W., Huang, J., Xia, S.-D., Jin, J.-M., Dong, F., Cheng, H., et al. (2019) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1900017 · Cited by 8
Prognostic Value of Late Gadolinium Enhancement in Predicting Life‐Threatening Arrhythmias in Heart Failure Patients With Implantable Cardioverter‐Defibrillators: A Systematic Review and Meta‐Analysis
Yue, T., Chen, B., Wu, L., Xu, J., & Pu, J. (2019) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26982 · Cited by 8
Defibrillator generator replacements in patients with left ventricular assist device support: The risks of hematoma and infection
Eulert‐Grehn, J., Sterner, I., Schoenrath, F., Stein, J., Mulzer, J., Kurz, S. D., Lanmüeller, P., Barthel, F., Unbehaun, A., Klein, C. A., et al. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.02.013 · Cited by 8
Cardiac unloading by LVAD support differentially influences components of the cGMP–PKG signaling pathway in ischemic and dilated cardiomyopathy
Persoon, S., Paulus, M. G., Hirt, S. W., Jungbauer, C. G., Dietl, A., Luchner, A., Schmid, C., Maier, L. S., & Birner, C. M. (2018) · Heart and Vessels · doi:10.1007/s00380-018-1149-x · Cited by 8
Primary Prevention Implantable Cardiac Defibrillators: A Townsville District Perspective
Engstrom, N., Dobson, G. P., Ng, K. K., & Letson, H. L. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.577248 · Cited by 8
Emery–Dreifuss muscular dystrophy: a closer look at cardiac complications
Kramarenko, D. R., & Walsh, R. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad735 · Cited by 8
Are the Four Pillars the Ideal Treatment for the Elderly?
Țica, O., Teodorovich, N., Champsi, A., & Swissa, M. (2023) · Cardiology · doi:10.1159/000531467 · Cited by 7
Ventricular-atrial coupling in subjects with normal, preserved, and reduced left ventricular ejection fraction: insights from cardiac magnetic resonance imaging
Zhou, D., Wang, Y., Li, S., Wu, W., Sun, X., Zhuang, B., He, J., Xu, J., Yang, W., Zhu, L., et al. (2023) · European Radiology · doi:10.1007/s00330-023-09801-y · Cited by 8
Arrhythmogenic Left Ventricular Cardiomyopathy: From Diagnosis to Risk Management
Mauriello, A., Roma, A. S., Ascrizzi, A., Molinari, R., Loffredo, F. S., D’Andrea, A., & Russo, V. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13071835 · Cited by 7
Preeclamptic heart failure — perioperative concerns and management: a narrative review
Bandyopadhyay, A., Puri, S., Samra, T., & Ashok, V. (2024) · Perioperative Medicine · doi:10.1186/s13741-024-00391-x · Cited by 7
Device-Therapy in Chronic Heart Failure: Cardiac Contractility Modulation Versus Cardiac Resynchronization Therapy
Yuecel, G., Gaasch, L., Kodeih, A., Hetjens, S., Yazdani, B., Pfleger, S., Duerschmied, D., Abraham, W. T., Akın, İ., & Kuschyk, J. (2024) · ESC Heart Failure · doi:10.1002/ehf2.15067 · Cited by 8
Fast interactive simulations of cardiac electrical activity in anatomically accurate heart structures by compressing sparse uniform cartesian grids
Kaboudian, A., Gray, R. A., Uzelac, I., Cherry, E. M., & Fenton, F. H. (2024) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2024.108456 · Cited by 7
Advancements in BATTERY longevity of cardiac implantable electronic devices from real‐world data: BATTERY study
Kuroda, M., Nagashima, M., Narita, M., Sasaki, W., Tanaka, N., Matsumoto, K., Naganuma, T., Mori, H., Ikeda, Y., Korai, K., et al. (2025) · Journal of Arrhythmia · doi:10.1002/joa3.70041 · Cited by 7
T1 Mapping and Major Cardiovascular Events in Non-Ischaemic Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis
Marchini, F., Passo, B. D., Campo, G. C., Tonet, E., Serenelli, M., Cossu, A., Chiarello, S., Monaco, M. L., Bertella, E., & Pavasini, R. (2025) · ESC Heart Failure · doi:10.1002/ehf2.15279 · Cited by 7
Chlorhexidine vs Povidone-Iodine Alcohol Solutions for Cardiac Implantable Electronic Devices
Costa, A. D., Mansourati, J., Eschalier, R., Lesaffre, F., Bordachar, P., Taieb, J., Laurent, G., Milhem, A., Kubala, M., Page, S. L. L., et al. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.10.042 · Cited by 7
Who still remains at risk of arrhythmic death at time of implantable cardioverter‐defibrillator generator replacement?
Madeira, M., António, N., Milner, J., Ventura, M., Cristóvão, J., Costa, M. A., Nascimento, J. H. M., Elvas, L., Gonçalves, L. M. M., & Pêgo, G. M. (2017) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13163 · Cited by 7
Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy with near-normal left ventricular ejection fraction
Bennett, R. G., Campbell, T. G., Kotake, Y., Turnbull, S., & Kumar, S. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.09.026 · Cited by 7
Clinical Determinants and Prognosis of Left Ventricular Reverse Remodelling in Non-Ischemic Dilated Cardiomyopathy
Díez‐López, C., Salazar‐Mendiguchía, J., García‐Romero, E., Fuentes, L., Lupón, J., Bayés‐Genís, A., Manito, N., de Antonio, M., Moliner, P., Zamora, E., et al. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9010020 · Cited by 7
Preliminary study on the diagnostic value of cardiac magnetic resonance feature tracking for malignant ventricular arrhythmias in non-ischemic dilated cardiomyopathy
Song, L., Zhao, X., Lv, W., Zeng, J., Wang, Y., Gong, B., Kalogeropoulos, A. P., Pu, H., Bai, Y., & Peng, S. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-660 · Cited by 7
Assessing physical activity with the wearable cardioverter defibrillator in patients with newly diagnosed heart failure
Iliodromitis, K. E., Balogh, Z., Triposkiadis, F. K., Deftereos, S. G., Vrachatis, D. A., Bimpong‐Buta, N., Schiedat, F., & Bogossian, H. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1176710 · Cited by 7
Implantable cardioverter defibrillator for primary prevention in patients with non-ischemic cardiomyopathy in the era of novel therapeutic agents- meta-analysis
Kolben, Y., Raccah, B. H., Koev, I. M., Luria, D. M., Amir, O., & Biton, Y. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1192101 · Cited by 7
Metabolomics Profiling Predicts Ventricular Arrhythmia in Patients with an Implantable Cardioverter Defibrillator
Yang, S., Zhao, J., Liu, X., Wang, J., Gu, M., Cai, C., Niu, H., Chen, L., & Hua, W. (2023) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-023-10413-6 · Cited by 8
Antiarrhythmic Treatment in Heart Failure
Könemann, H., Güler-Eren, S., Ellermann, C., Frommeyer, G., & Eckardt, L. (2024) · Current Heart Failure Reports · doi:10.1007/s11897-023-00642-w · Cited by 7
Clinical characteristics, treatment, trajectories and outcome of patients with dilated cardiomyopathy in a national heart failure registry
Carigi, S., Gentile, P., Gori, M., Tinti, M. D., Gennaro, L. D., Leonardi, G., Orso, F., Felici, A. R., Catalano, M. R., Floresta, M., et al. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.131986 · Cited by 7
Sudden death risk stratification in non-ischemic dilated cardiomyopathy using old and new tools: a clinical challenge
Manolis, A. S. (2017) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2017.1307735 · Cited by 7
Sudden cardiac death in inherited cardiomyopathy
Collis, R., & Elliot, P. M. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.04.006 · Cited by 7
Microvolt T-wave alternans and autonomic nervous system parameters can be helpful in the identification of low-arrhythmic risk patients with ischemic left ventricular systolic dysfunction
Daniłowicz‐Szymanowicz, L., Kaufmann, D., Rozwadowska, K., Kempa, M., Lewicka, E., & Raczak, G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196812 · Cited by 7
Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy
Okubo, K., Gigli, L., & Bella, P. E. D. (2018) · Journal of Arrhythmia · doi:10.1002/joa3.12099 · Cited by 7
Implantable Cardioverter-Defibrillators are the Main Link in the Modern Concept of Sudden Cardiac Death Prevention. Problems and Prospects of the Development of the Method
Bokeria, L. A., Neminushchiy, N. M., & Сергеевна, П. А. (2018) · Kardiologiia · doi:10.18087/cardio.2018.12.10197 · Cited by 7
Exercise training program in patients with NYHA III class systolic heart failure - Parallel comparison to the effects of resynchronization therapy
Bąk, E. S., Chwyczko, T., Kowalik, I., Borowiec, A., Maciąg, A., Szwed, H., & Dąbrowski, R. (2019) · Advances in Medical Sciences · doi:10.1016/j.advms.2018.12.006 · Cited by 7
Anti-arrhythmic therapy in patients with non-ischemic cardiomyopathy
Proietti, R., Russo, V., & AlTurki, A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.03.004 · Cited by 7
The Benefit of Prophylactic Implantable Cardioverter Defibrillator Implantation in Asymptomatic Heart Failure Patients With a Reduced Ejection Fraction
van der Lingen, A. C. J., Timmer, S. A. J., Allaart, L. J. H., Rijnierse, M. T., van de Ven, P. M., van Rossum, A. C., Kemme, M. J. B., van Halm, V. P., & Allaart, C. P. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.05.026 · Cited by 7
The risk and prevention of sudden death in patients with heart failure with reduced ejection fraction
Davis, J. S., & Sapp, J. L. (2019) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000710 · Cited by 7
Syncopes and Clinical Outcome in Heart Failure: Results from Prospective Clinical Study Data in Germany
Hashemi, D., Blum, M., Mende, M., Störk, S., Angermann, C. E., Pankuweit, S., Tahirović, E., Wachter, R., Pieske, B. M., Edelmann, F., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12605 · Cited by 7
N-terminal pro–B-type natriuretic peptide is a specific predictor of appropriate device therapies in patients with primary prevention implantable cardioverter-defibrillators
Sroubek, J., Matos, J. D., Locke, A. H., Kaplinskiy, V., Levine, Y. C., Shen, C., & Buxton, A. E. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.08.014 · Cited by 7
Downgrade of cardiac defibrillator devices to pacemakers in elderly heart failure patients: clinical considerations and the importance of shared decision-making
Groenveld, H. F., Coster, J. E., van Veldhuisen, D. J., Rienstra, M., Blaauw, Y., & Maass, A. H. (2021) · Netherlands Heart Journal · doi:10.1007/s12471-021-01555-w · Cited by 7
Cardiac Resynchronization and Defibrillator Therapy (CRT-D) or CRT Alone (CRT-P) in patients with dilated cardiomyopathy and heart failure without late gadolinium enhancement (LGE) cardiac magnetic resonance imaging (CMRI) high-risk markers - CRT-REALITY study - Study design and rationale
Táborský, M., Skála, T., Aiglová, R., Fedorco, M., Kautzner, J., Jandik, T., Vančura, V., Linhart, A., Válek, M., Novak, M., et al. (2021) · Biomedical Papers · doi:10.5507/bp.2021.015 · Cited by 7
Early ICD implantation in cardiac arrest survivors with acute coronary syndrome – predictors of implantation, ICD-therapy and long-term survival
Søholm, H., Laursen, M. L., Kjærgaard, J., Lindhardt, T. B., Hassager, C., Møller, J. E., Gregers, E., Linde, L., Johansen, J. B., Winther‐Jensen, M., et al. (2021) · Scandinavian Cardiovascular Journal · doi:10.1080/14017431.2021.1900597 · Cited by 7
Self-citation
‘Life with a device’: the octogenarians’ experiences with an implantable cardioverter-defibrillator—a qualitative study
Wising, J., Mattsson, G., Rambaree, K., Willmer, M., Wallhagen, M., & Magnusson, P. (2021) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvab033 · Cited by 7
Incidence and predictors of early and late sudden cardiac death in hospitalized Japanese patients with new‐onset systolic heart failure
Minami, Y., Kikuchi, N., Shiga, T., Suzuki, A., Shoda, M., & Hagiwara, N. (2021) · Journal of Arrhythmia · doi:10.1002/joa3.12618 · Cited by 7
Comparable Efficacy in Ischemic and Non-Ischemic ICD Recipients for the Primary Prevention of Sudden Cardiac Death
Ursaru, A. M., Costache, I. I., Petriş, A. O., & Tesloianu, D. N. (2021) · Biomedicines · doi:10.3390/biomedicines9111595 · Cited by 7
Impact of sacubitril/valsartan on systolic heart failure: Right heart location and clustering analysis
Bouali, Y., Galli, E., Paven, E., Clément, L., Hubert, A., Oger, E., & Donal, E. (2021) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/143433 · Cited by 7
Sudden cardiac death in heart failure with preserved ejection fraction: an updated review
Wu, S., & Hsieh, Y. (2022) · International Journal of Arrhythmia · doi:10.1186/s42444-021-00059-3 · Cited by 7
Spanish Implantable Cardioverter-defibrillator Registry. 15th Official Report of the Spanish Society of Cardiology Electrophysiology and Arrhythmias Section (2018)
Lozano, I. F., Osca, J., & Rodríguez, J. A. (2019) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2019.10.002 · Cited by 7
Elevated α-hydroxybutyrate dehydrogenase is associated with in-hospital mortality in non-ischemic dilated cardiomyopathy
Li, X., He, W., Zhang, X., Shu, F., Liu, Y., Tan, N., & Jiang, L. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.995899 · Cited by 7
Cardiac imaging for the prediction of sudden cardiac arrest in patients with heart failure
Lio, F. D., Andreis, A., LIO, G. D., Bellettini, M., Pidello, S., Raineri, C., Gallone, G., Alunni, G., Frea, S., Imazio, M., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17710 · Cited by 7
Rationales and choices for the treatment of patients with NYHA class II heart failure
Gilbert, E. M., & Xu, W. D. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1344082 · Cited by 7
Cardiac magnetic resonance imaging and primary prevention implantable cardioverter defibrillator therapy: current recommendations and future directions
Guaricci, A. I., Santis, D. D., Rabbat, M., & Pontone, G. (2018) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000650 · Cited by 7
Who Benefits From a Defibrillator—Balancing the Risk of Sudden Versus Non-sudden Death
Beggs, S. A. S., Gardner, R. S., & McMurray, J. J. V. (2018) · Current Heart Failure Reports · doi:10.1007/s11897-018-0416-6 · Cited by 7
Cardiac resynchronization therapy: a comprehensive review
Moskovitch, J. T., & Voskoboinik, A. (2019) · Minerva Medica · doi:10.23736/s0026-4806.18.05861-5 · Cited by 7
Risk factors for sudden cardiac death to determine high risk patients in specific patient populations that may benefit from a wearable defibrillator
Khan, H., & Leslie, S. J. (2019) · World Journal of Cardiology · doi:10.4330/wjc.v11.i3.103 · Cited by 7
Left Atrial Function Using Cardiovascular Magnetic Resonance Imaging Independently Predicts Life-Threatening Arrhythmias in Patients Referred to Receive a Primary Prevention Implantable Cardioverter Defibrillator
Lydell, C. P., Mikami, Y., Homer, K., Peng, M., Cornhill, A. K., Rajagopalan, A., Arasaratnam, P., Cowan, K. F., Roberts, A., Sumner, C., et al. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.04.015 · Cited by 7
For Whom the Bell Tolls
Tonchev, I., Luria, D. M., Orenstein, D., Lotan, C., & Biton, Y. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1191-z · Cited by 8
The Role of MRI in Prognostic Stratification of Cardiomyopathies
Grigoratos, C., Todiere, G., Barison, A., & Aquaro, G. D. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01311-3 · Cited by 7
Overweight and obesity as protective factors against mortality in nonischemic cardiomyopathy patients with an implantable cardioverter defibrillator
Zhou, B., Zhao, S., Tang, M., Chen, K., Hua, W., Su, Y., Chen, S., Liang, Z., Xu, W., Li, X., et al. (2020) · Clinical Cardiology · doi:10.1002/clc.23458 · Cited by 7
ICD therapy in the elderly: a retrospective single-center analysis of mortality
Scheurlen, C., van den Bruck, J., Wörmann, J., Plenge, T., Sultan, A., Steven, D., & Lüker, J. (2021) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-021-00742-x · Cited by 7
Preventive Implantable Cardioverter Defibrillator Therapy in Contemporary Clinical Practice: Need for More Stringent Selection Criteria
Deckers, J. W., Arshi, B., van den Berge, J. C., & Constantinescu, A. A. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13506 · Cited by 7
Management of ventricular arrhythmias in heart failure: Current perspectives
Peichl, P., Rafaj, A., & Kautzner, J. (2021) · Heart Rhythm O2 · doi:10.1016/j.hroo.2021.08.007 · Cited by 8
Nonsustained Ventricular Tachycardia at the Time of Implantation Predicts Appropriate Therapies on Rapid Ventricular Arrhythmia in Primary Prevention Patients With Nonischemic Cardiomyopathy
Clémenty, N., Bisson, A., Challal, F., André, C., Pierre, B., Fauchier, L., & Babuty, D. (2017) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2017.04.016 · Cited by 7
Nonarrhythmic Sudden Cardiac Death in Chronic Heart Failure—A Preventable Event?
Packer, M. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.2228 · Cited by 7
Prognostic role of left ventricular ejection fraction in heart failure: Back to the future?
Ambrosio, G., & Carluccio, E. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.09.025 · Cited by 7
Left ventricular reverse remodeling prediction in non-ischemic cardiomyopathy: present and perspectives
Masè, M., Merlo, M., Vitrella, G., Stolfo, D., & Sinagra, G. (2018) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2018.1533815 · Cited by 7
Left Atrial Strain in Dilated Cardiomyopathy
White, J. A. (2022) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2022.02.009 · Cited by 7
Jahresbericht 2020 des Deutschen Herzschrittmacher- und Defibrillator-Registers – Teil 2: Implantierbare Kardioverter-Defibrillatoren (ICD)
Markewitz, A., Nowak, B., Fröhlig, G., Lemke, B., WIEGAND, U. K. H., Kolb, C., & Bürger, H. (2022) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-022-00894-4 · Cited by 7
Sudden Death in Men Versus Women with Heart Failure
Martínez-Solano, J., & Martínez‐Sellés, M. (2023) · Current Heart Failure Reports · doi:10.1007/s11897-023-00596-z · Cited by 7
Prognostic Implications of Left Ventricular Ejection Fraction and Left Ventricular End-Diastolic Diameter on Clinical Outcomes in Patients with ICD
Cheng, S., Deng, Y., Huang, H., Liu, X., Yu, Y., Chen, X., Gu, M., Niu, H., & Hua, W. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9120421 · Cited by 6
One-Year Mortality in Patients Undergoing an Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy Pulse Generator Replacement: Identifying Patients at Risk
Feijen, M., Egorova, A. D., Kuijken, T., Bootsma, M., Schalij, M. J., & van Erven, L. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175654 · Cited by 6

Authors: Køber, L., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L., Korup, E., Jensen, G., Hildebrandt, P., Steffensen, F. H., Bruun, N. E., Eiskjær, H., Brandes, A., Thøgersen, A. M., Gustafsson, F., Egstrup, K., Videbæk, R., Hassager, C., Svendsen, J. H., Høfsten, D. E., Torp-Pedersen, C., & Pehrson, S.
Affiliations: University of Copenhagen (DK)
ORCID: Køber, Lars
Thune, Jens J.
Nielsen, Jens C.
Videbæk, Lars
Steffensen, Flemming H.
Bruun, Niels E.
Eiskjær, Hans
Brandes, Axel
Thøgersen, Anna M.
Gustafsson, Finn
Egstrup, Kenneth
Hassager, Christian
Svendsen, Jesper H.
Høfsten, Dan E.
Torp-Pedersen, Christian
Pehrson, Steen
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2016-09-29
Volume: 375
Issue: 13
Pages: 1221-1230
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1608029
OpenAlex: W2518530324
Cited by: 1,763
References: 18
Citations by year: 2026: 104 · 2025: 138 · 2024: 139 · 2023: 170 · 2022: 182 · 2021: 177 · 2020: 196 · 2019: 212 · 2018: 200 · 2017: 213 · 2016: 28
FWCI: 179.55
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion, other-oa)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Scopus (Elsevier) (submittedVersion)
VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
Funders: Bristol-Myers Squibb
Pfizer
AstraZeneca
Sanofi
Gilead Sciences
Hjerteforeningen
Boston Scientific Corporation
TrygFonden
Servier
St. Jude Medical
Biosense Webster
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Health Sciences › Medicine › Emergency Medicine › Cardiac Arrest and Resuscitation
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Keywords: implantable cardioverter-defibrillator, prophylactic ICD, heart failure with reduced ejection fraction, non-ischemic heart failure, sudden cardiac death, all-cause mortality, cardiac resynchronization therapy, device-related infection, left ventricular ejection fraction, DANISH trial
MeSH terms: Aged, Cardiac Pacing, Artificial, Cardiovascular Diseases, Electrocardiography, Female, Follow-Up Studies, Humans, Male, Middle Aged, Mortality, Stroke Volume, Death, Sudden, Cardiac, Defibrillators, Implantable, Heart Failure, Systolic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks